Conference
A multicenter, open-label, phase I/II study in patients with unresectable stage III non-small cell lung cancer (NSCLC) treated with L-BLP25: 2-year survival and safety results
Authors
Murray NR; Butts C; Smith C; Ellis PM; Jasas K; Maksymiuk A; Goss G; Ely G; Soulieres D
Volume
26
Pagination
pp. 3047-3047
Publisher
American Society of Clinical Oncology (ASCO)
Publication Date
May 20, 2008
DOI
10.1200/jco.2008.26.15_suppl.3047
Conference proceedings
Journal of Clinical Oncology
Issue
15_suppl
ISSN
0732-183X